These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 406098

  • 21. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE, Gorlin R, Mills RM, Williams RA, Schweitzer P, Ransil BJ.
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [Abstract] [Full Text] [Related]

  • 22. Preventive administration of intravenous N-acetylcysteine and development of tolerance to isosorbide dinitrate in patients with angina pectoris.
    Boesgaard S, Aldershvile J, Poulsen HE.
    Circulation; 1992 Jan; 85(1):143-9. PubMed ID: 1728443
    [Abstract] [Full Text] [Related]

  • 23. Effects of isosorbide dinitrate spray on central hemodynamics. Comparison with sublingual glyceryl trinitrate and isosorbide dinitrate.
    Saito M, Fukami K, Sumiyoshi T, Haze K, Hiramori K.
    Arzneimittelforschung; 1984 Jan; 34(6):707-9. PubMed ID: 6435644
    [Abstract] [Full Text] [Related]

  • 24. Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerin.
    Dalal JJ, Yao L, Parker JO.
    J Am Coll Cardiol; 1983 Jul; 2(1):115-20. PubMed ID: 6406586
    [No Abstract] [Full Text] [Related]

  • 25. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
    Marmor A.
    Am J Cardiol; 1990 Jun 04; 65(21):43J-45J. PubMed ID: 2112337
    [Abstract] [Full Text] [Related]

  • 26. [Comparative evaluation of the clinical effectiveness and the adverse effects of three different forms of nitrates in high oral doses in patients with stable angina pectoris].
    Kośmicki M, Kowalik I, Jedrzejczyk B, Sadowski Z.
    Pol Arch Med Wewn; 2002 Jun 04; 107(6):509-17. PubMed ID: 12371383
    [Abstract] [Full Text] [Related]

  • 27. The additive antianginal action of oral isosorbide dinitrate in patients receiving propranolol. Magnitude and duration of effect.
    Bassan MM, Weiler-Ravell D.
    Chest; 1983 Feb 04; 83(2):233-40. PubMed ID: 6822108
    [Abstract] [Full Text] [Related]

  • 28. High-dose isosorbide dinitrate in management of angina pectoris.
    Tremblay G.
    Am Heart J; 1985 Jul 04; 110(1 Pt 2):280-4. PubMed ID: 3925747
    [Abstract] [Full Text] [Related]

  • 29. Effect of swallowed isosorbide dinitrate on blood pressure, heart rate and exercise capacity in patients with coronary artery disease.
    Glancy DL, Richter MA, Ellis EV, Johnson W.
    Am J Med; 1977 Jan 04; 62(1):39-46. PubMed ID: 319662
    [Abstract] [Full Text] [Related]

  • 30. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy.
    Thadani U, Fung HL, Darke AC, Parker JO.
    Am J Cardiol; 1982 Feb 01; 49(2):411-9. PubMed ID: 7058754
    [Abstract] [Full Text] [Related]

  • 31. Nitroderm TTS in exercise-induced angina pectoris--a randomized double-blind study.
    Colombo G, Favini G, Aglieri S, Pollavini G, de Vita C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr 01; 23(4):211-4. PubMed ID: 3922903
    [Abstract] [Full Text] [Related]

  • 32. Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.
    Metelitsa VI, Martsevich SYu, Kozyreva MP, Slastnikova ID.
    Am J Cardiol; 1992 Feb 01; 69(4):291-6. PubMed ID: 1734637
    [Abstract] [Full Text] [Related]

  • 33. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O, Guéret P, Ferrier A, Léger P, Farcot JC, Rigaud M, Beaumont D, Bardet J, Bourdarias JP.
    Arch Mal Coeur Vaiss; 1983 Feb 01; 76(2):211-9. PubMed ID: 6407429
    [Abstract] [Full Text] [Related]

  • 34. Effect of a combination of pindolol and isosorbide dinitrate on ischemic ST-segment depression and exercise ability in angina pectoris.
    Dorow P, Schiess W.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug 01; 22(8):419-22. PubMed ID: 6386704
    [Abstract] [Full Text] [Related]

  • 35. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
    Kośmicki M, Sadowski Z.
    Wiad Lek; 2000 Aug 01; 53(7-8):388-93. PubMed ID: 11070759
    [Abstract] [Full Text] [Related]

  • 36. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
    Friedensohn A, Meshulam R, Schlesinger Z.
    Cardiology; 1991 Aug 01; 79 Suppl 2():31-40. PubMed ID: 1760827
    [Abstract] [Full Text] [Related]

  • 37. [Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
    Kośmicki M, Sadowski Z.
    Pol Arch Med Wewn; 1999 Nov 01; 102(5):967-72. PubMed ID: 11072531
    [Abstract] [Full Text] [Related]

  • 38. Antianginal effect of isosorbide dinitrate spray in patients with exercise-induced stable angina.
    Aärynen M, Soininen K.
    J Int Med Res; 1986 Nov 01; 14(6):303-5. PubMed ID: 3803701
    [Abstract] [Full Text] [Related]

  • 39. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct 01; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

  • 40. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
    Schneider W, Stahl B, Kaltenbach M, Bussmann WD.
    Dtsch Med Wochenschr; 1982 May 21; 107(20):771-6. PubMed ID: 7075499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.